Skip to main content
OpenTrials
Completed

NCT Number: NCT07342673

Vital Coach: A Study of Resiliency in Medical Students

Medical students often begin training with psychological and physiological health metrics superior to their age-matched peers. By graduation, however, rates of depression, anxiety, and physiologic dysregulation are markedly higher, reflecting the cumulative strain of long study hours, high-stakes examinations, and the emotional burden of early patient care. Despite this, few medical schools provide structured, evidence-based tools for students to develop resiliency and recovery skills before clinical rotations begin.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

About this study

This gap represents both a health crisis and an educational opportunity. Burnout originating in medical school often persists into residency and practice, diminishing empathy and professionalism, and contributing to long-term attrition. Existing wellness offerings are largely reactive, relying on voluntary counseling or broad wellness sessions that fail to provide individualized insight into students' physiological readiness or stress recovery capacity. Moreover, schools lack objective, continuous data to pinpoint when students are physiologically stressed to tailor timely support.

Against this backdrop, this study proposes evaluating a structured performance coaching and biometric feedback approach in the context of scheduled academic stressors. Arena Strive is a digital coaching platform that integrates a virtual human performance coach, wearable-derived biometric data, and a focused skills curriculum adapted from other high-stress domains and tailored to frontline healthcare workers. This novel intervention has proven effective in significantly reducing burnout and enhancing professional fulfillment and self-valuation in a large health-system through an 8-week intervention.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • active first year Wake Forest School of Medicine medical students
  • have an Android or iOS smart phone
  • are willing to download the Arena Strive application

Exclusion criteria

  • under the age of 18; or over the age of 60
  • pregnant at enrollment or during course of study
  • any self-reported cardiac conditions that may impact heart rate and heart rate variability

Treatment and study plan

Arena Strive

Behavioral

integrates asynchronous coaching, two virtual coaching sessions with a high-performance medicine coach, physiological data from wearable sensors, and a focused curriculum of performance tools tailored to frontline healthcare workers.

Other names: digital coaching platform

Primary outcomes

  1. Heart Rate Variability

    Time frame: Weekly through Week 13

    Mean daily nocturnal Heart Rate Variability (HRV): Higher = Better

  2. Resting Heart Rate (Beats per Minute)

    Time frame: Weekly through Week 13

    daily nocturnal Resting Heart Rate (RHR): Lower = Better

  3. Sleep Duration (minutes)

    Time frame: Weekly through Week 13

    Mean nightly sleep: Higher = Better

  4. Sleep Consistency (minutes)

    Time frame: Weekly through Week 13

    SD of mid-sleep time: Lower = Better

Secondary outcomes

  1. Change in Perceived Stress (Perceived Stress Scale PSS-4) Scores

    Time frame: Weekly through Week 13

    To score the Perceived Stress Scale 4 (PSS-4), first, reverse the scores for questions 2 and 3 (0 becomes 4, 1 becomes 3, 2 stays 2, 3 becomes 1, and 4 becomes 0). Then, add up the scores for all four questions. The total score will range from 0 to 16, with higher scores indicating greater perceived stress.

  2. Change in Burnout (Maslach Burnout Inventory MBI-GSS) Scores

    Time frame: Week 13

    MBI-GSS scoring involves summing responses for each of its three subscales: emotional exhaustion, cynicism, and professional efficacy, which are rated on a 7-point frequency scale from 0 (never) to 6 (daily). To determine burnout, high scores on exhaustion and cynicism indicate higher burnout, while low scores on professional efficacy suggest greater burnout. These subscale scores are then interpreted separately to understand the level of burnout for each dimension. Each item is rated on a frequency scale (e.g., 0 to 6), and higher or lower scores on each subscale indicate different levels of burnout.

Other outcomes

  1. Exam Performance checklist

    Time frame: Week 13

    Exam performance for the three exams during the study period is self-reported by participants via a typeform in the application at the study conclusion.

  2. Weekly mean nocturnal HRV (RMSSD, ms) measured via wearable device during intervention and compared to other phases.

    Time frame: Weekly through Week 13

    HRV will be assessed using the root mean square of successive differences (RMSSD, ms) to provide a daily individual score derived from nightly photoplethysmography (PPG) wearable-recorded data. All primary endpoints are computed at the individual level and compared by week, using week-level means (averaged from the individual daily scores). Heart Rate Variability (HRV) [RMSSD, ms] Individual Test= Like earlier mentioned tests these will include week-to-week differences for the weeks during the phase (Baseline Week, Study Week, Exam Week, Recovery Week) (ex. HRV_Recovery (during) - HRV_Exam (during) and comparisons with pre/post intervention phases (ex. HRV_Recovery (during) - HRV_Recovery (pre-intervention)).

    Group Test= A linear mixed model for HRV and PSS-4 with fixed effects for Week, Phase (0=pre, 1=post, 2=during) and a Week x Phase interaction, plus a random intercept for participant.

    Sensitivity Analyses= Paired t-tests (Wilcoxon as nonparametric alternative).

  3. Weekly mean nocturnal RHR (bpm) measured via wearable device during intervention and compared to other phases.

    Time frame: Weekly through Week 13

    Daily mean RHR (bpm) will be derived from nightly PPG wearable-recorded data. All primary endpoints are computed at the individual level and compared by week using week-level means (averaged from the individual daily scores). Resting Heart Rate (RHR) [bpm] Individual Test= Like earlier mentioned tests these will include week-to-week differences for the weeks during the phase (Baseline Week, Study Week, Exam Week, Recovery Week) (ex. RHR_Recovery (during) - RHR_Exam (during) and comparisons with pre/post intervention phases (ex. RHR_Recovery (during) - RHR_Recovery (pre-intervention)).

    Group Test= A linear mixed model for RHR and PSS-4 with fixed effects for Week, Phase (0=pre, 1=post, 2=during) and a Week x Phase interaction, plus a random intercept for participant.

    Sensitivity Analyses= Paired t-tests (Wilcoxon as nonparametric alternative).

  4. Weekly mean Sleep Duration (min) measured via wearable device during intervention and compared to other phases.

    Time frame: Weekly through Week 13

    Daily Sleep Duration (min) will be derived from nightly PPG wearable-recorded data. All primary endpoints are computed at the individual level and compared by week using week-level means (averaged from the individual daily scores). Sleep Duration [min] Individual Test= Like earlier mentioned tests these will include week-to-week differences for the weeks during the phase (Baseline Week, Study Week, Exam Week, Recovery Week) (ex. SleepDuration_Recovery (during) - Sleep Duration_Exam (during) and comparisons with pre/post intervention phases (ex. SleepDuration_Recovery (during) - SleepDuration_Recovery (pre-intervention)).

    Group Test= A linear mixed model for Sleep Duration and PSS-4 with fixed effects for Week, Phase (0=pre, 1=post, 2=during) and a Week x Phase interaction, plus a random intercept for participant.

    Sensitivity Analyses= Paired t-tests (Wilcoxon as nonparametric alternative).

  5. Weekly Sleep Consistency (SD of mid-sleep time, min) measured via wearable device during intervention and compared to other phases.

    Time frame: Weekly through Week 13

    Sleep Consistency will be measured as the standard deviation of nightly mid-sleep time derived from wearable-recorded sleep onset and offset times over each 7-day period, aggregated weekly at the individual level and compared across pre-intervention, intervention, and post-intervention phases. Sleep Consistency Individual Test= Like earlier mentioned tests these will include week-to-week differences for the weeks during the phase (Baseline Week, Study Week, Exam Week, Recovery Week) (ex. SleepConsistency_Recovery (during) - SleepConsistency_Exam (during) and comparisons with pre/post intervention phases (ex. SleepConsistency_Recovery (during) - SleepConsitency_Recovery (pre-intervention)).

    Group Test= A linear mixed model for Sleep Consistency and PSS-4 with fixed effects for Week, Phase (0=pre, 1=post, 2=during) and a Week x Phase interaction, plus a random intercept for participant.

    Sensitivity Analyses= Paired t-tests (Wilcoxon as nonparametric alternative).

  6. Heterogeneity of effects (sensitivity only)

    Time frame: Weekly through Week 13

    Moderation by demographics (age, race, gender) on primary outcomes.

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Registry information

Official study title

Vital Coach: A Study of Resiliency in Medical Students Using Wearable Technology and Personalized Wellness Coaching

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 15, 2026
Registry last updated
Jul 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.